Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Blood
01. April 2026
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8344
Articles 1 - 20 / 166863
EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N.
PMID: 41916363 [PubMed - in process]
HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41916353 [PubMed - in process]
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.
Blood Adv
Furman RR, Wierda WG, Patten PE, Chaves JM, Brown JR, Munir T, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos JC, Patel K, Woyach JA, de Borja M, Wang MH, Jain N, O'Brien SM MD, Byrd JC.
PMID: 41915892 [PubMed - as supplied by publisher]
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.
Blood
Gower N, Feugier P, Westin JR, Schiano de Colella JS, Tilly H, Palomba ML, Julia E, Damaj GL, Durand A, Flinn IW, Lemonnier F, Morineau N, Ysebaert L, Bartlett N, Thieblemont C, Ribrag V, Gastinne T, Arthur D, Fouillet L, Guidez S, Houot R, da Silva MG, Barnes J, Bijou F, Cartron G, Martin Garcia-Sancho AM, Eradat HA, Cheminant M, López-Guillermo AL, Abrisqueta P, Abraham J, Sarkozy C, Izutsu K, Crochet G, Sehn LH, Gkasiamis A, Yge ML, Chartier L, Fowler NH, Xerri L, Salles GA, Morschhauser F.
PMID: 41915772 [PubMed - as supplied by publisher]
Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial.
Cancer Immunol Immunother
Ghasabeh AS, Izadpanah A, Bakhtiyaridovvombaygi M, Seresht-Ahmadi M, Parkhideh S, Seraji HR, Sabri A, Yazdanparast S, Hajifathali A, Gharehbaghian A, Roshandel E.
PMID: 41915180 [PubMed - indexed for MEDLINE]
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study.
Int J Hematol
Ogasawara F, Minami Y, Chi S, Ueda T, Fukushima K, Kojima K.
PMID: 41915141 [PubMed - as supplied by publisher]
Relationships Between Clinician-Patient Communication and the Quality of Life of Patients With Leukaemia: A Prospective Cross-Sectional Global Study.
Cancer Control
Nier S, Poots AJ, Gunn S, Oliva EN, Ionova T, Salek S.
PMID: 41914705 [PubMed - indexed for MEDLINE]
Incidence and Risk Factors of Serious Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia: AÂ CYP-C Population-Based Study.
Pediatr Blood Cancer
de Villiers N, Éthier C, Laverdière C, Alos N, Tran TH, Pelland-Marcotte MC.
PMID: 41914452 [PubMed - as supplied by publisher]
Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm.
Cancer
Perrone S, De Fazio L, Monachetti S, Molica M.
PMID: 41914434 [PubMed - indexed for MEDLINE]
Potential Application of CAR-NK Cells as an Ex Vivo Therapy for T-cell-related Diseases.
Front Biosci (Landmark Ed)
Kwon D, Kang KS.
PMID: 41914298 [PubMed - indexed for MEDLINE]
Navigating the Landscape of Antibody Drug Conjugates: Current Trends and Future Research Prospects in Acute Myeloid Leukemia.
Front Biosci (Elite Ed)
Shah AC, Saluja SG, Trivedi JD, Mehta SH, Patel R, Chorawala MR, Dudhat K, Prajapati BG.
PMID: 41914165 [PubMed - indexed for MEDLINE]
Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.
Indian J Pathol Microbiol
Sarjana, Jasmita, Agarwal M, Ganesh V, Mahapatra M.
PMID: 41913419 [PubMed - indexed for MEDLINE]
Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study.
Oncologist
Lokhorst DN, van den Bemt BJF, Smit Y, Hermens RPMG, Blijlevens NMA, Bekker CL.
PMID: 41913063 [PubMed - as supplied by publisher]
HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41911849 [PubMed - in process]
HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41911838 [PubMed - in process]
HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J.
PMID: 41911756 [PubMed - in process]
CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA.
J Natl Compr Canc Netw
Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N.
PMID: 41911732 [PubMed - in process]
Transforming Acute Myeloid Leukemia Care Through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies.
Oncology
Al-Shibly R, Benkhadra M, Yassin MA.
PMID: 41911081 [PubMed - as supplied by publisher]
LM-101, an anti-SIRPα antibody, in patients with relapsed/refractory lymphoma and advanced head and neck cancer: an open-label, multicenter, phase 1 trial.
Clin Cancer Res
Cai J, Zhao B, Ji D, Zhou F, Bai S, Fang X, Nie M, Bai B, Zhang Y, Li J, Li H, Li Y, Fei D, Qin X, Qin C, Zhao S, Xia Y, Cai Q.
PMID: 41910591 [PubMed - as supplied by publisher]
Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment.
Expert Rev Clin Pharmacol
Marvin-Peek J, Jen WY, Ravandi F.
PMID: 41910474 [PubMed - as supplied by publisher]
Articles 1 - 20 / 166863
Page 1 of 8344
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy